why choose us

First received: May 26, 2023

Clinical Trial: miR-155 Expression in Episodic and Chronic Migraine

Study Status: Completed

Recruit Status: RECRUITING

Condition: Migraine

Study Type: OBSERVATIONAL


Official Title: Expression of miR-155 in Migraine: Association With Different Phenotypes and Disease Severity

Brief Summary: Migraine is a common, yet often disabling, neurological disease that affects over 1 billion people around the world.It's the second most disabling disease globally and the leading cause of disability for people under the age of 50, especially women.The effects of migraine aren't limited to the individual, with a tremendous economic impact on families, friends, and employers.To help reduce this burden, research is now focusing on developing biomarkers that can help with diagnosis, predicting response to…

Read more